Resettable Dose Driver Decoupling for Drug Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Resettable drug delivery devices are complex, bulky, and difficult to use due to numerous components, requiring users to disassemble the device to replace cartridges and reset the dose setting mechanism, which is not intuitive and increases manufacturing costs.

Innovation Solution

A drug delivery device with a resettable dose setting mechanism featuring a driver with a first and second component that rotate together during dose setting, but are decoupled during resetting, allowing the first component to move axially and reset the spindle to an initial position, simplifying the resetting process and reducing the number of components.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If a resettable dose setting mechanism is implemented, then the device can be reused after cartridge replacement, but the device complexity increases due to numerous components

Engineering Contradiction:
ImprovereusabilityVSAvoidnumber of components
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The driver is divided into a first component and a second component that can rotate together during dose setting but are decoupled during resetting. This segmentation allows the resetting function to be achieved with simpler mechanical interactions, reducing overall device complexity while maintaining reusability

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The first driver component serves multiple functions: it rotates with the second component during dose setting and also functions as the resetting mechanism when decoupled. This multi-functionality reduces the need for separate dedicated resetting components, thereby reducing device complexity while enabling reusability

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If the device structure is made robust with multiple components, then reliability improves, but the device size increases making it bulky

Engineering Contradiction:
Improvedevice robustnessVSAvoiddevice size
Core Design Contradiction:
ReliabilityVSVolume of moving object

Solution Approach 1:

The resetting function is merged into the existing driver components rather than being implemented as a separate mechanism. The first driver component both drives the spindle during dosing and performs resetting when decoupled, eliminating the need for additional resetting components and reducing device volume while maintaining reliability

Inventive Principle:
Principle #5Merging (Combining)

3Reliability

If the dose setting mechanism requires disassembly for resetting, then component protection is improved, but ease of operation deteriorates

Engineering Contradiction:
Improvecomponent protectionVSAvoidresetting ease
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The device performs resetting automatically through the decoupling of the first and second driver components without requiring user disassembly. The mechanical design enables the resetting function to be activated simply by removing the cartridge, which automatically triggers the decoupling and resetting sequence, improving ease of operation while maintaining component protection through the controlled decoupling mechanism

Inventive Principle:
Principle #25Self-service

Data Source

PatentEP2529774B1Resetting mechanism for a drug delivery device
Publication Date: 2022.08.17 SANOFI AVENTIS DEUT GMBH
  • EP2529774B1 patent drawingFigure 1~2
  • EP2529774B1 patent drawingFigure 3
  • EP2529774B1 patent drawingFigure 4

AI summary

A resettable dose setting mechanism for a drug delivery device comprising a driver for driving a spindle of the drug delivery device is provided. Said driver comprises a first component (44; 207) and a second component (46; 212) rotationally coupled to said first component (44; 207). During resetting of said drug delivery device, said first component (44; 207) is rotationally decoupled from said second component (46; 212).